companies innovating obesity treatment glp-1 drugs 2025 Pipeline Update: February - Prime Therapeutics Beyond GLP-1: the next wave

Before undergoing this therapy, select a reputable provider who can enlighten you on the costs associated and the likely outcomes

Prior authorization denial rates for GLP-1 obesity prescriptions have been high, and industry reporting through 2024 put them well above half of requests in some plans

Before attributing hair loss to aging alone, women should ask a clinician to check ferritin, thyroid function, and hormone levels, since correcting an underlying cause often produces better results than any peptide

334 A phase I study is ongoing to evaluate AG-270 in advanced solid tumors and lymphomas (NCT03435250)

Hangover Recovery Rooftop bars at The Bungalow, dinners on Main Street, and nights that drift from the Promenade to Venice

Independent of alcohol exposure, pharmacological-mediated increases in PAGln elicits direct cardiac and vascular dysfunction